CD73 INHIBITORS

Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases. En la presente se describen inhibidores de CD73 y composiciones farmacéuticas que...

Full description

Saved in:
Bibliographic Details
Main Authors ZHU Liusheng, MOORE Jared, BLANK Brian R, YEH Chien-hung, FANTIN Valeria R, ZAVOROTINSKAYA Tatiana, KAWAI Hiroyuki, SUN Daqing, REW Yosup, PHAM Johnny, YE Qiuping, EKSTEROWICZ John, WU Kejia, DU Xiaohui
Format Patent
LanguageEnglish
Spanish
Published 25.08.2022
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases. En la presente se describen inhibidores de CD73 y composiciones farmacéuticas que comprenden dichos compuestos. Los compuestos y composiciones en cuestión son útiles para el tratamiento de cánceres, infecciones y enfermedades neurodegenerativas.
Bibliography:Application Number: MX2022005256